BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.83+0.01 (+0.61%)
Close on Nov 13, 2026Market cap $12.58MP/E –Yield –
BioCardia market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BioCardia's market cap was $13.81M on Nov 11, 2026, against $15.38M a year earlier. Over the last 5 years it ranged from $4.95M to $809.05M, with a median of $17.08M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $13.81M | +4.1% |
| 2025 | Dec 31, 2025 | $13.26M | +34.5% |
| 2024 | Dec 31, 2024 | $9.86M | -95.4% |
| 2023 | Dec 29, 2023 | $214.03M | -61.7% |
| 2022 | Dec 30, 2022 | $559.32M | +13.9% |
| 2021 | Dec 31, 2021 | $490.93M | -23.9% |
| 2020 | Dec 31, 2020 | $645.02M | +71.2% |
| 2019 | Dec 31, 2019 | $376.73M | -45.3% |
| 2018 | Dec 31, 2018 | $688.97M | -48.8% |
| 2017 | Dec 29, 2017 | $1.34B | -63.0% |
| 2016 | Dec 30, 2016 | $3.64B | +1252.6% |
| 2015 | Dec 31, 2015 | $268.88M | -27.3% |
| 2014 | Dec 31, 2014 | $369.71M | +37.5% |
| 2013 | Dec 31, 2013 | $268.88M | +33.3% |
| 2012 | Dec 31, 2012 | $201.66M | -14.3% |
| 2011 | Dec 30, 2011 | $235.27M | – |
See a number that looks wrong?